Efficacy of Adenosine in Patients With Acute Myocardial Infa... : Medicine Efficacy of Adenosine
in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary …

Background: Studies evaluating intracoronary administration of adenosine for prevention of
microvascular dysfunction and ischemic-reperfusion injury in patients with acute myocardial …

Aims Adenosine has been tested in several randomized controlled trials (RCTs) to minimize
the incidence of coronary microvascular obstruction (CMVO). The aim of this study was to …

Early reperfusion represents the key strategy in ST elevation myocardial infarction. However,
reperfusion may induce myocardial damage due to the reperfusion myocardial injury …

Aims The purpose of this analysis was to determine whether the efficacy of adenosine vs.
placebo was dependent on the timing of reperfusion therapy in the second Acute Myocardial …

The concept of reperfusion injury, although first recognized from animal studies, is now
recognized as a clinical phenomenon that may result in microvascular damage, no-reflow …

The mainstay of acute myocardial infarction has long been timely reperfusion of the culprit
obstruction. Reperfusion injury resulting from a multitude of pathophysiological processes …

Background The definitive treatment for myocardial ischemia is reperfusion. However,
reperfusion injury has the potential to cause additional reversible and irreversible damage to …

Background Adenosine administered as an adjunct to reperfusion can reduce coronary no-
reflow and limit myocardial infarct (MI) size in ST-segment elevation myocardial infarction …

Although early reperfusion and maintained patency is the mainstay therapy for ST elevation
myocardial infarction, experimental studies demonstrate that reperfusion per se induces …